Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
Status:
Withdrawn
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT)
in reducing atherosclerotic plaques inflammation and increasing peak walking time (PWT) among
peripheral artery disease (PAD) patients with symptom of intermittent claudication.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University